Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase

• Burcu Aslan,
• Stefan Edward Hubner,
• Judith A. Fox,
• Pietro Taverna,
• William G. Wierda,
• Steven M. Kornblau,
• Varsha Gandhi

Affiliations

Burcu Aslan

Department of Experimental Therapeutics

Stefan Edward Hubner

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

Judith A. Fox

Sunesis Pharmaceuticals, Inc., South San Francisco

Pietro Taverna

Sunesis Pharmaceuticals, Inc., South San Francisco

William G. Wierda

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

Steven M. Kornblau

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

Varsha Gandhi

Department of Experimental Therapeutics; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston